F
Fennec Pharmaceuticals
FENC
6.26300
USD
-0.217
(-3.35%)
مغلق
حجم التداول
634
الربح لكل سهم
0
العائد الربحي
0
P/E
65
حجم السوق
123,960,438
العنوان: Fennec Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.